Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > 750,000 CAD Volume
View:
Post by DavidKingCanada on Sep 20, 2021 8:50pm

750,000 CAD Volume

A few comments;

- Serology Test is BS - End of Story - Will not see Increase in SP.
- Compared to 1 Year prior we are at the same SP yet now we have a 80 Mil Cap. 
- 431 Million Shares NOT including the ones on Hold.
- Penny stock for the last Decade. 
- Buyout would be beneficial to both the Company and Shareholders.  
- M101 makes zero sense.
- I said it before and I will say it again. Wait 3-5 Years and prosper.
- RC, thanks for trying bud.
Comment by JackRedwood on Sep 21, 2021 8:17am
SP should definitely be higher, I just can't fathom the current CEO's Half a Mil Salary
Comment by BottomBroker on Sep 21, 2021 11:38am
Agreed on serology test. See recent story from the New York Times below. Agreed on buyout, depending on how it's structured.  Agreed on 3-5 years, but maybe even 2 years. Disagreed on M101. He seems to know this company well and for the most part knows why the share price does what it does. I trust his opinion above all others on this board.  RC has been here the longest, but has ...more  
Comment by retiredcop on Sep 21, 2021 1:37pm
To add to the excitement..if you go the immunity passport site..the"  COMING Soon" serology test..the printing is now 4 times the font size it used to be...this means something is really close to happening ....and for interest sake....I have been posting on this site for almost 15 years and I have a perfect unsullied record...nothing I have ever predicted to happen has actually come ...more  
Comment by M101 on Sep 21, 2021 1:57pm
I'm actually surprised that the pp holders continue to liquidate at .18, although I expect it's still at no loss so free warrants.  The chart now looks like last year only at twice the time scale and ready to break downward any day, but I don't see the logic of doing so.  Not that logic matters, trading is pathologic. At some point next year traders are going to start piling ...more  
Comment by JackRedwood on Sep 23, 2021 8:05am
Thanks for everyone's input, lots of great information here! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities